Abstract
The biomedical community made a fundamental error on the nature of the dose-response relationship early in the 20th century and has perpetuated this error to the present. The error was the byproduct of the conflict between homeopathy and traditional medicine. To deny support to homeopathy, leaders of the biomedical community rejected the hormetic biphasic dose-response model, the proposed explanatory principle of homeopathy. The threshold dose-response model was adopted as an alternative model, quickly becoming central to toxicology/pharmacology and their numerous applications. Despite its near-universal acceptance, no attempt was made to validate the ability of the threshold model to accurately predict responses in the below-threshold zone at the time of acceptance and throughout the 20th century. In contrast, the hormetic biphasic dose-response model became marginalized and was excluded from the mainstream of pharmacological/toxicological teaching and practice, textbook development, professional society journal publications, annual meeting presentations, grant funding, and use in government risk assessment. Over the last decade there has been a resurgence of interest in hormesis due to findings indicating that hormetic responses are common, reproducible, and generalizable, as well as independent of biological model, endpoint, and chemical class/physical stressor. Large-scale studies have indicated that the threshold model fails to accurately predict responses below the threshold, whereas the hormetic dose-response model performs very well. These findings indicate that the biomedical community made an error on the nature of the dose-response relationship, compromising the accuracy of toxicological and risk assessment practices, including environmental exposure standards, and impeding drug discovery/development and drug safety studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berliner H (1985) A System of Scientific Medicine. Philanthropic foundations in the Flexner era. New York: Tavistock Publications.
Bliss CI (1935) The calculation of the dosage-mortality curve. Ann Appl Biol 22: 134–167.
Bohme H (1986) Hugo Schulz (8/6/1853–7/13/1932) his life and work. Dissertation from the Medical Department of the Free University of Berlin. Translated from the German by Julia M. Ryan, University of Massachusetts, Amherst.
Bors J, Zimmer K (1970) Effects of low doses of x-rays on rooting and yield of carnation. Stimulation News l 1: 16–21.
Boyera N, Galey I, Bernard BA (1997) Biphasic effects of minoxidil on the proliferation and differentiation of normal human keratinocytes. Skin Pharmacol 10: 206–220.
Branham SE (1929) The effects of certain chemical compounds upon the course of gas production by baker’s yeast. J Bacteriol 18: 247–264.
Bruce RD, Carlton WW, Ferber KH, Hughes DH, Quast JF, Salsburg DS, Smith JM (Members of the Society of Toxicology ED01 Task Force) (1981) Re-examination of the ED01 study—adjusting for time on study. Fund Appl Toxicol 1: 67–80.
Calabrese EJ (2008a) Pharmacological enhancement of neuronal survival. Crit Rev Toxicol 38: 349–389.
Calabrese EJ (2008b) Enhancing and regulating neurite outgrowth. Crit Rev Toxicol 38: 391–418.
Calabrese EJ (2008c) Alzheimer’s disease drugs: an application of the hormetic dose response model. Crit Rev Toxicol 38: 419–452.
Calabrese EJ (2008d) Pain and U-shaped dose responses: occurrence, mechanisms and clinical implications. Crit Rev Toxicol 38: 579–590.
Calabrese EJ (2008e) Stress biology and hormesis: the Yerkes-Dodson law in psychology: a special case of the hormesis dose-response. Crit Rev Toxicol 38: 453–462.
Calabrese EJ (2008f) An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit Rev Toxicol 38: 489–542.
Calabrese EJ (2008 g) Modulation of the epileptic seizure threshold: implications of biphasic dose responses. Crit Rev Toxicol 38: 543–556.
Calabrese EJ (2008 h) Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms and clinical implications. Crit Rev Toxicol 38: 557–577.
Calabrese EJ (2008i) Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson law are manifestations of hormesis. Ageing Res Rev 7: 8–20.
Calabrese EJ (2008j) Hormesis and mixtures. Toxicol Appl Pharmacol 229: 262–263.
Calabrese EJ (2007) Threshold-dose-response model—RIP: 1911 to 2006. BioEssays 29: 686–688.
Calabrese EJ (2005a) Historical blunders: how toxicology got the dose-response relationship half right. Cell Mol Biol 51: 643–654.
Calabrese EJ (2005b) Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit Rev Toxicol 35: 89–295.
Calabrese EJ (2005c) Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol 35, 463–582.
Calabrese EJ (2005d) Toxicological awakenings: the rebirth of hormesis as a central pillar of toxicology. Toxicol Appl Pharmacol 204: 1–8.
Calabrese EJ (2003a) Chemotherapeutics and hormesis. Crit Rev Toxicol 33: 305–354.
Calabrese EJ (2003b) Inorganics and hormesis. Crit Rev Toxicol 33: 215–304.
Calabrese EJ (2001a) Apoptosis: biphasic dose responses. Crit Rev Toxicol 31: 607–614.
Calabrese EJ (2001b) Cell migration/chemotaxis: biphasic dose responses. Crit Rev Toxicol 31: 524–615.
Calabrese EJ (2001c) Dopamine: biphasic dose responses. Crit Rev Toxicol 31: 563–584.
Calabrese EJ (2001d) Nitric oxide: biphasic dose responses. Crit Rev Toxicol 31: 489–502.
Calabrese EJ (2001e) Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol 31: 503–516.
Calabrese EJ (2001f) Androgens: biphasic dose responses. Crit Rev Toxicol 31: 517–522.
Calabrese EJ (2001 g) 5-Hydroxytryptamine (serotonin): biphasic dose responses. Crit Rev Toxicol 31: 553–562.
Calabrese EJ (2001 h) Opiates: biphasic dose responses. Crit Rev Toxicol 31: 585–604.
Calabrese EJ (2001i) Adrenergic receptors: biphasic dose responses. Crit Rev Toxicol 31: 523–538.
Calabrese EJ (1991) Multiple chemical interactions. Chelsea, MI: Lewis Publishers.
Calabrese EJ (1985) Uncertainty factors and interindividual variation. Regul Toxicol Pharmacol 5: 190–196.
Calabrese EJ, Baldwin LA (2003a) The hormetic dose response model is more common than the threshold model in toxicology. Toxicol Sci 71: 246–250.
Calabrese EJ, Baldwin LA (2003b) Chemotherapeutics and hormesis. Crit Rev Toxicol 33: 305–353.
Calabrese EJ, Baldwin LA (2002) Hormesis and high risk groups. Regul Toxicol Pharmacol 35: 414–428.
Calabrese EJ, Baldwin LA (2001) The frequency of U-shaped dose-responses in the toxicological literature. Toxicol Sci 62: 330–338.
Calabrese EJ, Baldwin LA (2000a) Chemical hormesis: its historical foundations as a biological hypothesis. Hum Exp Toxicol 19: 2–31.
Calabrese EJ, Baldwin LA (2000b) The marginalization of hormesis. Hum Exp Toxicol 19: 32–40
Calabrese EJ, Baldwin LA (2000c) Radiation hormesis: its historical foundations as a biological hypothesis Hum Exp Toxicol 19: 41–75.
Calabrese EJ, Baldwin LA (2000d) Radiation hormesis: the demise of a legitimate hypothesis. Hum Exp Toxicol 19: 76–84.
Calabrese EJ, Baldwin LA (2000e) Tales of two similar hypotheses: the rise and fall of chemical and radiation hormesis. Hum Exp Toxicol 19: 85–97.
Calabrese EJ, Baldwin LA (1997) The dose determines the stimulation (and poison): development of a chemical hormesis database. Int J Toxicol 16: 545–559.
Calabrese EJ, Blain R (2005) The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol 202: 289–301.
Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, Cedergreen N, Cherian MG, Chiueh CC, Clarkson TW, Cook RR, Diamon DM, Doolittle DJ, Dorato MA, Duke SO, Feinendegen L, Gardner DE, Hart RW, Hastings KL, Hayes AW, Hoffmann GR, Ives JA, Jaworowski Z, Johnson TE, Jonas WB, Kaminski NE, Keller JG, Klaunig JE, Knudsen TB, Kozumbo WJ, Lettieri T, Liu S-Z, Maisseu A, Maynard KI, Masoro EJ, McClellan RO, Mehendale HM, Mothersill C, Newlin DB, Nigg HN, Oehme FW, Phalen RF, Philbert MA, Rattan SIS, Riviere JE, Rodricks J, Sapolsky RM, Scott BR, Seymour C, Sinclair DA, Smith-Sonneborn J, Snow ET, Spear L, Stevenson DE, Thomas Y, Tubiana M, Williams GM, Mattson MP (2007) Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 222: 122–128.
Calabrese EJ, Staudenmayer JW, Stanek EJ, Hoffmann GR (2006) Hormesis outperforms threshold model in NCI anti-tumor drug screening data. Toxicol Sci 94: 368–378.
Calder WA (1996) Size, function, and life history Mineola, NY: Dover Publications.
Chueh S-C, Guh J-H, Chen J, Lai M-K, Teng C-M (2001) Dual effects of ouabain on the regulation of proliferation and apoptosis in human prostatic smooth muscle cells. J Urol 166: 347–353.
Cicero TJ, Badger TM (1977) Effects of alcohol on the hypothalamic-pituitary-gonadal axis in the male rat. J Pharmacol Exp Ther 201: 427–433.
Clark AJ (1937) Handbook of experimental pharmacology. Berlin: Verlag Julius Springer.
Clark AJ (1933) Mode of action of drugs on Cells. London: Arnold.
Clark AJ (1927) The historical aspects of quackery, Part 2. Br Med J 2: 960.
Cookson MR, Mead C, Austwick SM, Pentreath VW (1995) Use of the MTT assay for estimating toxicity in primary astrocyte and C6 glioma cell cultures. Toxicol in Vitro 9: 39–48.
Crump T (2003) Contemporary medicine as presented by its practitioners themselves, Leipzig, 1923:217–250. Hugo Schulz. Nonlinearity Biol Toxicol Med 1: 295–318
Davies, JMS, Lowry, CV, and Davies, KJA (1995) Transient adaptation to oxidative stressing yeast. Arch Biochem Biophys 317: 1–6.
Flexner A (1910) Medical education in the United States and Canada. A report to the Carnegie Foundation for the Advancement of Teaching. New York.
Flood JF, Smith GE, Cherkin A (1985) Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice. Psychopharmacology 86: 61–67.
Flood JF, Smith GE, Cherkin A (1983) Memory retention: potentiation of cholinergic drug combinations in mice. Neurobiol Aging 4: 37–43.
Foekens JA, Sieuwerts AM, Stuurman-Smeets EMJ, Dorssers LCJ, Berns EMJJ, Klijn JGM (1992) Pleiotropic actions of suramin on the proliferation of human breast cancer cells in vitro. Int J Cancer 51: 439–444.
Foley GE,, Winter WD (1949) Increased mortality following penicillin therapy of chick embryos infected with Candida albicans var Stellatoidea. J Infect Dis 85: 268–274.
Fornaro E, Li D, Pan J, Belik J (2007) Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat. Am J Respir Crit Care Med 176: 1035–1040.
Fukushima S, Kinoshita A, Puatanachokchai R, Kushida M, Wanibuchi H, Morimura K (2005) Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. Carcinogenesis 26: 1835–1845.
Gaddum JH (1962) Pharmacologists of Edinburgh. Annu Rev Pharmacol Toxicol 2: 1–10.
Gaddum JH (1933) Methods of biological assay depending on the quantal response. London: His Majesty’s Stationery Office.
Garrod LP (1951) The reactions of bacteria to chemotherapeutic agents. Br Med J 1: 205–210.
Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G (1998) Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoglastogenesis in young and aged mice in vivo. Bone 22: 455–461.
Goerig M, Agarwal K, Esch JS (2000) The versatile August Bier (1861–1949), father of spinal anesthesia. J Clin Anesth 12: 561–569.
Honar H, Riazi K, Homayoun H, Sadeghipour H, Rashidi N, Ebrahimkhani MR, Mirazi N, Dehpour AR (2004) Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures. Neuroscience 129: 733–742.
Hunter PE, Krithayakiern V (1971) Effect of gamma radiation upon life expectancy and reproduction in the house cricket, Acheta domesticus (orthopter: Gryllidae). Ann Entomol Soc Am 64: 119–123.
Im HK, Im WB, Pregenzer JF, Carter DB, Jacobsen EJ, Hamilton BJ (1995) Characterization of U-97775 as a GABAA receptor ligand of dual functionality in cloned rat GABAA receptor subtypes. Br J Pharmacol 115: 19–24.
Jacobsen EJ, TenBrink RE, Stelzer LS, Belonga KL, Carter DB, Im HK, Im WB, Sethy VH, Tang AH, VonVoigtlander PF, Petke, JD (1996a) High affinity partial agonist imidazol[1,5-a]quinoxaline amides, carbamate, and ureas at the γ-aminobutyric acid A/benzodiazepine receptor complex. J Med Chem 39: 158–175.
Jacobsen EJ, Stelzer LS, Belonga KL, Carter DB, Im WB, Sethy VH, Tang AH, VonVoigtlander PF, Petke JD (1996b) 3-Phenyl-substituted imidazo[1,5-a]quinoxalin-4-ones and imidazol[1,5-a]quinoxaline ureas that have high affinity at the GABAA/benzodiazepine receptor complex. J Med Chem 39: 3820–3836.
Jacobsen EJ, Stelzer LS, TenBrink RE, Belonga KL, Carter DB, Im HK, Im WB, Sethy VH, Tang AH, VonVoigtlander PF, Petke JD, Zhong WZ, Mickelson JW (1999) Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality. J Med Chem 42: 1123–1144.
Lee JB, Hayashi K, Hayashi T, Sankawa U, Maeda M (1999) Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum. Planta Med 65: 439–441.
Lehman AJ (1954) Untitled. Assoc Food Drug Off 18: 33.
Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguezportales J, Downs RW, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333: 1437–1443.
McGaugh JL, Petrinovich LF (1965) Effects of drugs on learning and memory. Int Rev Neurobiol 8: 139–196.
Melchior CL, Ritzmann RF (1994) Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav 47: 427–441.
Meng G (1993) Effects of arsenic on DNA synthesis in human lymphocytes. Arch Environ Contam Toxicol 25: 525–528.
Merkel LA, Lappe RW, Rivera LM, Cox BF, Perrone MH (1992) Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. J Pharmacol Exp Ther 260: 437–443.
Miller WS, Green CA, Kitchen H (1945) Biphasic action of penicillin and other sulphonamide similarity. Nature 155: 210–211.
Murrell GAC, Francis MJO, Bromley L (1990) Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265: 659–665.
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 75: 534–537.
Mutscheller A (1925) Physical standards of protection against Roentgen ray dangers. Am J Roentgenol 13: 65–69.
National Academy of Sciences (NAS) (1977) Drinking water and health. Washington, DC: National Academy of Sciences.
National Council on Radiation Protection and Measurements (NCRPM) (1954) Permissible dose from external sources of ionizing radiation. Washington, DC: U.S. Department of Commerce.
Nyberg K, Ekblad M, Bergstrom T, Freeman C, Parish CR, Ferro V, Trybala E (2004) The low molecular weight heparin sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res 63: 15–24.
Paalzow GHM, Paalzow LK (1985) Promethazine both facilitates and inhibits nociception in rats: effect of the testing procedure. Psychopharmacology 85: 31–36.
Paalzow GHM, Paalzow LK (1983a) Opposing effects of apomorphine on pain in rats. Evaluation of the dose-response curve. Eur J Pharmacol 88: 27–35.
Paalzow GHM, Paalzow LK (1983b) Yohimbine both increases and decreases nociceptive thresholds in rats evaluation of the dose-response relationship. Naunyn-Schmied Arch Pharmacol 322: 193–197.
Parkhurst BR, Bradshaw AS, Forte JL, Wright GP (1981) The chronic toxicity to Daphnia magna of acridine, a representative azarene present in synthetic fossil fuel products and wastewater. Environ Pollut (Series A) 24: 21–30.
Rai UN, Gupta M, Tripathi RD, Chandra P (1998) Cadmium regulated nitrate reductase activity in Hydrilla verticillata (1f) Royle. Water Soil Air Pollut 106: 171–177.
Randall WA, Price CW, Welch H (1947) Demonstration of hormesis (increase in fatality rate) by penicillin. Am J Public Health 37: 421–425.
Rossini M, Gatti D, Zamberlan N, Braga V, Dorizzi R, Adami S (1994) Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Miner Res 9: 1833–1837.
Sandifer RD, Hopkin SP (1997) Effects of temperature on the relative toxicities of Cd, Cu, Pb, and Zn to Folsomia candida (collembolan). Ecotoxicol Environ Safety 37: 125–130
Schulz H (1888) Uber Hefegifte. Pfluger’s Archiv Gesamte Physiol 42: 517–541.
Schulz H (1885) About the treatment of cholera nostras with veratrine [in German].Deutsch Arzneipflanzen Forsch Wochenzeit 11: 99–100. [Translated by Julia M. Ryan, University of Massachusetts, Amherst.]
Southam CM, Ehrlich J (1943) Effects of extract of Western red-cedar heartwood on certain wood-decaying fungi in culture. Phytopathology 33: 517–524.
Starke K (1998) A history of Naunyn-Schmiedeberg’s Archives of Pharmacology. Naunyn-Schmied Arch Pharmacol 358: 1–109.
Sukata T, Uwagawa S, Ozaki K, Ogawa M, Nishikawa T, Iwai S, Kinoshita A, Wanibuchi H, Imaoka S, Funae Y, Okuno Y, Fukushima S (2002) Detailed low-dose study of 1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane carcinogenesis suggests the possibility of a hormetic effect. Int J Cancer 99: 112–118.
Ungar J, Muggleton P (1946) The effect of penicillin on the growth of human type M tuberculosis. J Pathol Bacteriol 58: 501–504.
U.S. Environmental Protection Agency (U.S. EPA) (1986) Guidelines for the health risk assessment of chemical mixtures. Fed Regist 57: 34014–34025.
Verney EB, Barcroft J (1941) AJ Clark (Obituary). Obituary Notices Fellows. Roy Soc 3: 969.
Vieira VLP , Rocha JBT, Schetinger MRC , Morsch VM , Rodrigues SR , Tuerlinckz SM , Bohrer D, do Nascimento PC (2000) Effect of aluminum on δ-aminolevulinic acid dehydratase from mouse blood. Toxicol Lett 117: 45–52.
Welch H, Price CW, Randall WA (1946) Increase in fatality rate of E. typhosa for white mice by streptomycin. J Am Pharmaceut Assoc 35: 155–158.
Wiedman SJ, Appleby AP (1972) Plant growth stimulation by sublethal concentrations of herbicides. Weed Res 12: 65–74.
Wise LE, Lichtman AH (2007) The uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task. Eur J Pharmacol 575: 98–102.
Wu W-C, Kao Y-H, Hu D-N (2002) A comparative study of effects of antiproliferative drugs on human retinal pigment epithelial cells in vitro. J Ocular Pharmacol Ther 18: 251–264.
Acknowledgment s
This work was sponsored by the Air Force Office of Scientific Research, Air Force Material Command, USAF, under grant number FA9550-07-1-0248. The U.S. Government is authorized to reproduce and distribute reprints for governmental purposes notwithstanding any copyright notation hereon. The views and conclusions contained herein are those of the author and should not be interpreted as necessarily representing the official policies or endorsement, either expressed or implied, of the Air Force Office of Scientific Research or the U.S. Government.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Calabrese, E.J. (2010). Hormesis: Once Marginalized, Evidence Now Supports Hormesis as the Most Fundamental Dose Response. In: Mattson, M., Calabrese, E. (eds) Hormesis. Humana Press. https://doi.org/10.1007/978-1-60761-495-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-60761-495-1_2
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-494-4
Online ISBN: 978-1-60761-495-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)